HEALTHPEAK PROPERTIES INC (PEAK) Forecast, Price Target & Analyst Ratings

NYSE:PEAK • US42250P1030

Current stock price

17.1 USD
+0.35 (+2.09%)
At close:
17.1 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTHPEAK PROPERTIES INC (PEAK).

Forecast Snapshot

Consensus Price Target

Price Target
$22.19
+ 29.74% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2024
EPS Estimate
$0.07
Revenue Estimate
582.07M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.18%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$22.19
Upside
+ 29.74%
From current price of $17.10 to mean target of $22.19, Based on 22 analyst forecasts
Low
$18.18
Median
$22.95
High
$27.30

Price Target Revisions

1 Month
-1.34%
3 Months
2.46%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for PEAK. The average price target is 22.19 USD. This implies a price increase of 29.74% is expected in the next year compared to the current price of 17.1.
The average price target has been revised upward by 2.46% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PEAK Current Analyst RatingPEAK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

PEAK Historical Analyst RatingsPEAK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
78.18%
PEAK was analyzed by 22 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about PEAK.
In the previous month the buy percentage consensus was at a similar level.
PEAK was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-03-04ScotiaBankMaintains Sector Outperform -> Sector Outperform
2024-01-30Deutsche BankInitiate Hold
2024-01-12ScotiaBankUpgrade Sector Perform -> Sector Outperform
2023-10-31WedbushReiterate Neutral -> Neutral
2023-10-11Exane BNP ParibasInitiate Underperform
2023-10-05ScotiaBankMaintains Sector Perform -> Sector Perform
2023-10-03WedbushInitiate Neutral
2023-09-07Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2023-07-25BarclaysMaintains Overweight -> Overweight
2023-06-15MizuhoReiterate Buy -> Buy
2023-06-15CitigroupReiterate Neutral -> Neutral
2023-06-12MizuhoReiterate Buy -> Buy
2023-05-04RBC CapitalMaintains Sector Perform
2023-04-24MizuhoUpgrade Neutral -> Buy
2023-04-20Wells FargoInitiate Equal-Weight
2023-04-19Wells FargoInitiate Equal-Weight
2023-04-06CitigroupDowngrade Buy -> Neutral
2023-03-31ScotiaBankDowngrade Sector Outperform -> Sector Perform
2023-03-10Morgan StanleyMaintains Equal-Weight
2023-02-28CitigroupMaintains Buy
2023-02-10BarclaysMaintains Overweight
2023-01-03JefferiesUpgrade Hold -> Buy
2022-12-14RBC CapitalDowngrade Outperform -> Sector Perform
2022-11-21Evercore ISI GroupUpgrade In-Line -> Outperform
2022-11-01Morgan StanleyMaintains Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2024
EPS Estimate
$0.07
Revenue Estimate
582.07M
Revenue Q2Q
10.72%
EPS Q2Q
-68.70%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-1.28%
Revenue (3 Months)
-1.28%
EPS (1 Month)
-15.63%
EPS (3 Months)
-7.95%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 1.28% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
PEAK revenue by date.PEAK revenue by date.
1.896B
15.28%		2.061B
8.70%		2.181B
5.81%		2.55B
16.92%		2.708B
6.20%		2.827B
4.39%		N/AN/AN/AN/A
EBITDA
YoY % growth
PEAK ebitda by date.PEAK ebitda by date.
1.035B
13.11%		1.105B
6.72%		1.198B
8.40%		1.364B
13.89%		1.43B
4.84%		1.466B
2.52%		1.674B
14.19%		1.772B
5.85%		1.869B
5.47%		1.965B
5.14%
EBIT
YoY % growth
PEAK ebit by date.PEAK ebit by date.
350.9M
60.89%		394.2M
12.34%		447.745M
13.58%		637.4M
42.36%		806.11M
26.47%		859.04M
6.57%		524.28M
-38.97%		605M
15.40%		647.36M
7.00%		688.19M
6.31%
Operating Margin
PEAK operating margin by date.PEAK operating margin by date.
18.51%19.12%20.53%25.00%29.77%30.39%N/AN/AN/AN/A
EPS
YoY % growth
PEAK eps by date.PEAK eps by date.
0.61
-27.38%		0.92
50.16%		0.56
-38.86%		0.39
-30.18%		0.56
43.04%		0.47
-15.20%		0.38
-20.43%		0.47
24.32%		0.51
8.70%		0.56
10.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.07
-68.70%		0.09
2.00%		0.13
6.25%		0.14
3.96%		0.14
107.41%		0.15
66.67%		0.16
28.00%		0.17
24.53%
Revenue
Q2Q % growth		582.07M
10.72%		679.36M
24.56%		698.55M
25.59%		705.34M
27.40%		643.98M
10.64%		647.5M
-4.69%		650.86M
-6.83%		652.95M
-7.43%
EBITDA
Q2Q % growth		332.68M
18.64%		397.08M
-16.82%		407.45M
-39.84%		413.67M
-52.99%		344.42M
3.53%		345.61M
-12.96%		349.25M
-14.28%		349.96M
-15.40%
EBIT
Q2Q % growth		177.85M
75.74%		263.52M
161.95%		291.47M
151.48%		299.08M
130.07%		197.27M
10.92%		198.8M
-24.56%		205.12M
-29.63%		204.92M
-31.48%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PEAK Yearly Revenue VS EstimatesPEAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
PEAK Yearly EPS VS EstimatesPEAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-5.39%
EPS Next 5 Year
-3.48%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.55%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
49.06%
EBIT Next 5 Year
31.97%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HEALTHPEAK PROPERTIES INC / PEAK Forecast FAQ

What do analysts expect the price target to be for HEALTHPEAK PROPERTIES INC (PEAK)?

22 analysts have analysed PEAK and the average price target is 22.19 USD. This implies a price increase of 29.74% is expected in the next year compared to the current price of 17.1.

What are the consensus estimates for HEALTHPEAK PROPERTIES INC (PEAK) next earnings?

The consensus EPS estimate for the next earnings of HEALTHPEAK PROPERTIES INC (PEAK) is 0.07 USD and the consensus revenue estimate is 582.07M USD.

What is the expected long term growth rate for HEALTHPEAK PROPERTIES INC (PEAK)?

The expected long term growth rate for HEALTHPEAK PROPERTIES INC (PEAK) is 8.55%.